Abstract
Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study target for cancer. The effect of SPRY2 in colorectal cancer (C......
小提示:本篇文献需要登录阅读全文,点击跳转登录